MATTHEW WELLINGTON

Advocating for FDA to follow through on its proposed rules to take menthol cigarettes and flavored cigars off the market. We also signed onto letters to the House and Senate leadership asking them not to interfere with the FDA's tobacco control efforts.

Met with members of white house team to push for policies relating to reducing antibiotic use on farms as part of the administration's pandemic preparedness efforts.

Lobbied for efforts to reduce antibiotic use on farms, including through FDA policy, appropriations through Congress. Also lobbied for bills Fair Repair Act (H.R. 4006, S. 3830), Freedom to Repair Act (H.R. 6566).

Signed numerous letters urging FDA to move quickly to eliminate menthol cigarettes, and lobbied Congress to give FDA authority to regulate synthetic nicotine products as tobacco products.

Lobbied Rep Golden with Environment Maine for his support on the infrastructure bill, working to make sure they included clean car initiatives etc. in the final bill.

Met with Rep. Krishnamoorthi's office about writing a letter to the CDC about establishing a PPE clearinghouse. Lobbied several congressional offices on the Baby Food Safety Act (HR 2229), pitching them on co-sponsoring it. Lobbied House and Senate offices to push the FDA to act quicker to set duration limits on antibiotics used in agriculture. Included pitching a dear colleague sign on letter and also working with offices on their own letters to the FDA. We also worked to convince House/Senate offices to include more money for the FDA in the appropriations bill, and to include language in it that would force the FDA to move quicker. Supported consumer protections from surprise medical billing, especially ambulatory care.

Lobbied on an antibiotics bill that Rep. Mike Doyle's office is drafting, lobbied several offices about appropriations pushing for the FDA to move quicker in establishing duration limits on all medically important antibiotics in animal agriculture, lobbied Senator Gillibrand office on a bill about disease surveillance on farms that they're planning ton introduce, lobbied the FDA directly asking them to move quicker to establish duration limits on medically important antibiotics.

Lobbied on antibiotics in farm animals and meat, suprise billing and ambulance commission and healthcare. Lobbied Rep. Krishnamoorthi and Senator Blumenthal on the need for a government sponsored clearinghouse for PPE. Also lobbied Krishnamoorthi office about a new bill to establish safety standards on toxic metals in baby food. Participate in remote meetings with House/Senate and FTC official on privacy, consumer protection and competition matters. 26 January 2021- Join letter to Senate Judiciary and Commerce Committee leadership urging strong opposition to confirmation of any Big Tech lobbyists, lawyers or executives to positions where they could influence oversight of Big Tech regulation or antitrust or competition actions. 19 February 2021-Join petition to FTC requesting investigation of deceptive and unfair practices by the Edtech platform "Prodigy." 24 February 2021-Join letter to Senator Richard Blumenthal, new chair of Manufacturing, Trade, and Consumer Protection Subcommittee, Senate Commerce Committee, urging that only strong consumer safety advocates be considered for Consumer product Safety Commission. 29 March 2021-Join letter to FCC urging implementation of long-delaying regulations on illegal robocalls. (Written Ex Parte Presentation Rules & Regulations Implementing the Telephone Consumer Protection Act of 1991, CG Docket No. 02-278)

Lobbied the Trump Admin to boost production of PPE through the Defense Production Act, lobbied Senate and the House to include the Medical Supply Transparency and Delivery Act into its COVID package. Lobbied the House and Senate to include more money for testing and PPE into the COVID package. Supported ending the practice of surprise medical billing. Lobbied for appropriations legislation that would include language limiting duration of medically important antibiotic use in agriculture. Lobbied House office of Rep. Mike Doyle to draft and introduce antibiotic related legislation.

Supported the Medical Supply Transparency and Delivery Act in the Senate (meetings with Balwdin, Murphy, Gardner, Daines, Hawley, Sinema, Tillis, McSally). Supported House HEROES Act (H.R. 6800) and updated House HEROES Act (H.R. 8406). Opposed Senate COVID-19 skinny bill (S. 4775). Met with Rep Doyle staff to discuss potential for a new bill on antibiotics that would address innovation and ag.

Supported the Medical Supply Transparency and Delivery Act, which would establish central, transparent coordination of the medical supply chain.

Lobbied both members of the House and Senate to support funding for FDA to establish duration limits on all medically important antibiotics approved for use in food animals. We were asking for general support and also circulated a dear colleague letter in the House.

Lobbied EPA and members of House about proposal to spray antibiotics on citrus trees, lobbied FDA and members of House to establish duration limits on all medically important antibiotics in food animals. Also lobbied members of House on Preservation of Antibiotics for Medical Treatment Act.

Lobbied Rep. Krishnamoorthi on e-cigarettes legislation to prohibit all flavored products, and lobbied FDA to do the same.

Lobbied legislators in Congress to try and block an EPA proposal that would expand spraying antibiotics on citrus trees. Support the re-introduction of the Preservation of Antibiotics for Medical Treatment Act.

Lobbying FDA to prohibit all flavored tobacco products. Lobbying FDA to take e-cigarettes off the market until they're properly reviewed (see comment on proposal Docket No. FDA-2019-D-0661). Support the "Stopping Appealing Flavors in E-Cigarettes for Kids (SAFE Kids) Act".

Lobbying against EPA's proposed expansion of streptomycin on citrus fields: Docket # EPA-HQ-OPP-2016-0067. Support the Preservation of Antibiotics for Medical Treatment Act. Lobbying for a general hearing through Energy and Commerce of antibiotic resistance, generally working to influence policies to reduce antibiotic use on farms.

Lobbied Rep. Pallone and Senator King staff about the need to regulate e-cigarettes to reduce youth use. Developed materials calling on the FDA to prohibit the sale of flavored tobacco products, along with taking the products off the market pending the appropriate review and regulation.

Supported the Preservation of Antibiotics for Medical Treatment Act (HR 1587) and Preventing Antibiotic Resistance Act (S 629). Urged FDA to prohibit routine use of antibiotics in food-producing animals. Urged EPA to reject proposal to expand spraying the antibiotic streptomycin on citrus groves. Made a public comment to the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria urging it to prohibit routine use of antibiotics in food-producing animals.

H.R. 5554, Animal Drug User Fee Act, we lobbied to cut conditional approval expansion and include duration limits on all medically important antibiotics. S 3099 Strengthening Antibiotic Oversight Act, we lobbied for legislators to co-sponsor the bill.

H.R. 5554, Animal Drug User Fee Act, we lobbied to cut conditional approval expansion and include duration limits on all medically important antibiotics. S 3099 Strengthening Antibiotic Oversight Act, we lobbied for legislators to co-sponsor the bill.